Electrical Stimulation and Expression of VEGF and NO in Diabetic Foot Ulcer

NCT ID: NCT02019082

Last Updated: 2013-12-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-03-31

Study Completion Date

2011-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to investigate the effect of low intensity cathodal direct current on the release of plasma vascular endothelial growth factor (VEGF) and nitric oxide (NO) in diabetic foot ulceration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Twenty type 2 diabetic patients with foot ulceration and 13 age-matched healthy subjects were enrolled. Patients were randomly assigned to electrical stimulation (ES, n=10) or sham ES (placebo, n=10) groups. ES group received cathodal direct current for 1 h/day, 3 days/week, for 4 weeks (12 sessions). Blood sample was collected for VEGF and NO measurement in the first and last treatment sessions before and after intervention. Wound surface area (WSA) and skin temperature were measured at 1st, 6th, and 12th session.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetic Foot Ulcer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

electrical stimulation

electrical stimulation group, group who received direct current ES at sensory threshold intensity for 1 h/day, 3 days/week, for 4 weeks (12 sessions)

Group Type ACTIVE_COMPARATOR

Electrical Stimulation (BTL-5000 series, United Kingdom)

Intervention Type DEVICE

Direct current ES

placebo

In the placebo group, the treatment procedure was the same as that the ES group, but the current intensity was zero.

Group Type PLACEBO_COMPARATOR

placebo

Intervention Type DEVICE

the intervention procedure was the same as that the ES group, but the current intensity was zero

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Electrical Stimulation (BTL-5000 series, United Kingdom)

Direct current ES

Intervention Type DEVICE

placebo

the intervention procedure was the same as that the ES group, but the current intensity was zero

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Wagner classification DFU 2;
* age 40-60 years;
* mild to moderate diabetic neuropathy;
* ABI\>0.7
* wound surface area\>1.5cm2

Exclusion Criteria

* fracture in a lower limb,
* a severe infection,
* a malignancy,
* kidney failure,
* skin diseases,
* osteomyelitis,
* pregnancy,
Minimum Eligible Age

40 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

giti torkaman

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

giti torkaman

professor

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

giti torkaman, PhD

Role: STUDY_DIRECTOR

professor of physical therapy, physical therapy department, faculty of medical sciences, tarbiat modares univercity

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Physical Therapy Department, Faculty of Medical Sciences

Tehran, , Iran

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Iran

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

د 50/259

Identifier Type: -

Identifier Source: org_study_id